Skip to main content

Get the latest public health information from CDC

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Guidelines search

Search Guidelines

  • Archived Guidelines (1)
  • Guidance for COVID-19 and People with HIV (2)
  • Guidelines for Caring for Persons with HIV in Disaster Areas (4)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (18)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (34)
  • HIV Clinical Guidelines: Pediatric ARV (19)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (32)
  • Perinatal HIV Clinical Guidelines (18)
Search Results 1 – 20 of 364
Fostemsavir (Rukobia, FTR)
Pre-exposure Prophylaxis (PrEP) to Prevent HIV During Periconception, Antepartum, and Postpartum Periods
Herpes (HHV-8/CMV)
Fostemsavir
Cabotegravir
What to Start: Initial Combination Regimens for the Antiretroviral-Naive Patient
Protease Inhibitor-Based Regimens
Table 9. Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy
Other Antiretroviral Regimens for Initial Therapy When Abacavir, Tenofovir Alafenamide, and Tenofovir Disoproxil Fumarate Cannot Be Used or Are Not Optimal
Table 7. Antiretroviral Regimen Considerations for Initial Therapy Based on Specific Clinical Scenarios
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens
Integrase Strand Transfer Inhibitor–Based Regimens
Nucleoside Reverse Transcriptase Inhibitor Options as Part of Initial Therapy
Drug Interactions Between HIV-1 gp120-Directed Attachment Inhibitors and Other Drugs (Including Antiretroviral Agents)
Table 10. Antiretroviral Components or Regimens Not Recommended as Initial Therapy
All Archived Guidelines
Adult and Adolescent ARV Archive
Adult and Adolescent Opportunistic Infection Archive
Pediatric ARV Archive
Pediatric Opportunistic Infection Archive

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • …
  • Next page ›
  • Last page ››

CONNECT WITH US

Facebook
Twitter
Instagram
Email Updates

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Mobile Application
  • Resources
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.